Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

FINANCIAL INSTRUMENTS (Narrative) (Details)

v3.22.1
FINANCIAL INSTRUMENTS (Narrative) (Details)
$ / shares in Units, $ / shares in Units, € in Thousands, ₪ in Thousands, £ in Thousands, $ in Thousands, $ in Thousands
 12 Months Ended
May 10, 2021
CAD ($)
Shares
shares
May 10, 2021
USD ($)
Shares
$ / shares
Dec. 31, 2021
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2020
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2021
EUR (€)
Shares
shares
Dec. 31, 2021
GBP (£)
Shares
shares
Dec. 31, 2021
ILS (₪)
Shares
shares
Dec. 31, 2021
USD ($)
Shares
shares
May 10, 2021
$ / shares
Feb. 12, 2021
$ / shares
Disclosure of detailed information about financial instruments [line items]                    
Exercise price of warrants exercisable | $ / shares     $ 1.3             $ 5.20
Net proceeds from private placement     $ 28,131 $ 0            
Finance costs     $ 1,648 $ 20,504            
Exercise price of compensation option | $ / shares     $ 2.43 $ 1.8            
Number of share options granted in share-based payment arrangement | Shares     2,964,265 905,000            
Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares     $ 6.2 $ 4.24            
Aggregate consideration to acquire preferred shares     $ 13 $ 1,347            
Investments     2,429 2,341            
Investments in unlisted shares measured at fair value     2,429              
Outstanding balance of 2 loans     $ 2,710 $ 0            
Number of shares issued | shares     68,217,894 39,765,799 68,217,894 68,217,894 68,217,894 68,217,894    
Issuance of new warrants     $ 11,832              
Fair value of the investments     2,429 $ 2,341            
2019 Warrants [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Fair value of warrants     $ 16,540            
Amount of warrant transferred in equity during the period     $ (611)              
Number of warrants outstanding | Shares     0 9,729,264 0 0 0 0    
(Gain) loss on revaluation     $ 15,929 $ (16,283)            
2021 Warrant [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Term of warrants from date of issuance 5 years 5 years                
Fair value of warrants     $ 6,022              
Issuance expenses including FV of compensation units $ 3,800                  
Number of warrants outstanding | Shares     3,043,478   3,043,478 3,043,478 3,043,478 3,043,478    
(Gain) loss on revaluation     $ 5,810              
Number of warrants issued for common shares | Shares 3,043,478 3,043,478                
Number of common shares called by warrants | shares 3,043,478                  
Exercise price of warrants issued per common share | $ / shares   $ 7.2                
Issuance of new warrants $ 30,670                  
Warrant liability 11,832                  
2021 Warrant [Member] | Listed Warrants [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Issuance expenses including FV of compensation units 1,296                  
2021 Warrant [Member] | Share Capital [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Issuance expenses including FV of compensation units 2,539                  
Overnight Marketed Offering [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Net proceeds from private placement $ 42,502 $ 35,000                
Number of share options granted in share-based payment arrangement | Shares 913,044 913,044                
Number of shares issued | shares 6,086,956                  
Par value per share | $ / shares                 $ 5.75  
Number of warrants issued for common shares | Shares 456,522 456,522                
Share-based compensation $ 800                  
Currency risk [Member] | Cash And Cash Equivalent [Member] | EUR [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Risk exposure associated with instruments sharing characteristic     1,069   € 742          
Currency risk [Member] | Cash And Cash Equivalent [Member] | NIS [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Risk exposure associated with instruments sharing characteristic     6,845       ₪ 16,718      
Currency risk [Member] | Cash And Cash Equivalent [Member] | USD [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Risk exposure associated with instruments sharing characteristic     1,447         $ 1,136    
Currency risk [Member] | Cash And Cash Equivalent [Member] | GBP [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Risk exposure associated with instruments sharing characteristic     $ 9     £ 2